Oral anticoagulant treatment in very elderly patients with atrial fibrillation

Comprehensive Therapy

Volumn 27, Issue 1, 2001, Pages 7-10

  Pengo, V ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ATTENTION; BLEEDING; BRAIN EMBOLISM; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; ELDERLY CARE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL DECISION MAKING; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOSIS;

EID: 0035103495     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-001-0002-8     Document Type: Article

References (36)

1. Atrial fibrillation as an independent factor for stroke: The Framingham study
2. Coronary heart disease and atrial fibrillation: The Framingham study
3. Epidemiologic features of chronic atrial fibrillation: The Framingham study
4. Prevalence of cardiovascular diseases and diabetes mellitus in residents of Rochester, Minnesota
5. Atrial fibrillation: A major contributor to stroke in the elderly. The Framingham study
6. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation
7. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study
8. Stroke Prevention in Atrial Fibrillation Study. Final results
9. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
10. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study
11. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
12. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
13. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation Stroke Prevention in Atrial Fibrillation II Study
14. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial
15. Double-blind randomized trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
16. Fixed minidose warfarin and aspirin alone and in combination vs. adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study
17. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation
18. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial
19. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
20. Antithrombotic therapy in atrial fibrillation
21. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaboratory study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy
22. The risk for and the severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics
23. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
24. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study
25. Echocardiographic predictors of stroke in patients with atrial fibrillation: A prospective study of 1,066 patients from 3 clinical trials
26. Optimal oral anticoagulant therapy in patients with mechanical heart valves
27. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy
28. Prospective evaluation of an index for predicting the risk of major bleeding in out-patients treated with warfarin
29. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic
30. Advantages of a specific ambulatory for patients following oral anticoagulant therapy
31. Assessment of mental ability in elderly anticoagulated patients: Its reduction is associated with a less satisfactory quality of treatment
32. Preventing stroke in patients with atrial fibrillation
33. Status of antithrombotic therapy in patients with atrial fibrillation in university hospitals
34. Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals
35. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting
36. Oral anticoagulation in patients with atrial fibrillation: Adherence with guidelines in an elderly cohort